2021. Bedaquiline-a potential inhibitor of COVID-19 main protease based on molecular docking. International Journal of Research in Pharmacology & Pharmacotherapeutics. 9, 2 (Mar. 2021), 136–144. DOI:https://doi.org/10.61096/ijrpp.v9.iss2.2020.136-144.